Kyoto, Japan

Hiroshi Ochi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Epo-Med Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Ochi. Retrieved from https://idiyas.com/inventor/hiroshi-ochi-l17upz0d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Ochi: Innovator in Peptide Technology

Introduction

Hiroshi Ochi is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of peptide technology, particularly with his innovative work on anti-erythropoietin receptor peptides. His research has the potential to impact various medical applications.

Latest Patents

Hiroshi Ochi holds a patent for an anti-EpoR peptide. The patent describes a peptide with a specific structure that includes various amino acids and modifications. This invention aims to provide a novel approach to targeting erythropoietin receptors, which could have implications in treating certain medical conditions.

Career Highlights

Ochi is associated with Epo-Med Inc., where he continues to advance his research in peptide technology. His work has garnered attention in the scientific community, showcasing his dedication to innovation and development in this specialized field.

Collaborations

Hiroshi Ochi collaborates with esteemed colleagues such as Hiroyuki Kouji and Yoshiko Yasuda. These partnerships enhance the research environment and contribute to the advancement of their collective work in peptide technology.

Conclusion

Hiroshi Ochi's contributions to peptide technology, particularly through his patent on anti-erythropoietin receptor peptides, highlight his role as an innovator in the field. His ongoing work at Epo-Med Inc. and collaborations with fellow researchers further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…